2026.01.22 G.S.R. 52(E)_Draft Notification for Revision of testing fees under Schedule B and B1

CDSCO (India)

REGULATION

Published: 1/22/2026Detected: 3/22/2026

Revises the testing fees under Schedule B and B1, impacting the financial obligations of manufacturers and developers for regulatory compliance.

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

#testing fees

#regulatory compliance

#Schedule B

#Schedule B1

#Regulatory Compliance

Access the original document directly from INDIA CDSCO.

Free plan, 2-minute setup, no credit card required.

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Not affiliated with the FDA, EMA, or Health Canada.